GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)

NCT04673149 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: GLS-5310
BIOLOGICAL: Placebo

Sponsor

GeneOne Life Science, Inc.